fluconazole has been researched along with chitosan in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 13 (54.17) | 2.80 |
| Authors | Studies |
|---|---|
| Bikiaris, D; Georgarakis, E; Kanaze, FI; Karavas, E; Papageorgiou, GZ; Stergiou, A | 1 |
| Alburquenque, C; Bucarey, SA; Hermosilla, G; Neira-Carrillo, A; Tapia, CV; Urzúa, B | 1 |
| Azcurra, AI; Barembaum, SR; Berdicevski, N; Bojanich, MA; Calamari, SE | 1 |
| de Freitas, O; Gelfuso, GM; Gratieri, T; Lopez, RF; Rocha, EM | 1 |
| Conesa, A; Gebbia, M; Giaever, G; Heisler, LE; Jaime, MD; Lee, AY; Lopez-Llorca, LV; Nislow, C; Proctor, M; Westwood, JT | 1 |
| Ahmadi, MS; Davies, KP; Friedman, AJ; Lee, HH; Martinez, LR; Nosanchuk, JD; Sanchez, DA; Tar, MT | 1 |
| Eraç, B; Ertan, G; Güneri, P; Gurer-Orhan, H; Hoşgör-Limoncu, M; Karavana, SY; Nenni, M; Özbal, S; Pekçetin, Ç; Rençber, S; Yılmaz, FF | 1 |
| Ahmed, N; Imran, M; Khan, GM; Naz, K; Qureshi, NA; Sarwar, HS; Shahnaz, G | 1 |
| Barad, S; Daryasari, MP; Omran, AN; Roudbary, M | 1 |
| Al-Duais, MA; Alalawy, AI; Almutairi, FM; El Rabey, HA; Sakran, MI; Tayel, AA; Zidan, NS | 1 |
| Lopes, AI; Pintado, ME; Tavaria, FK | 1 |
| Aam, BB; Eijsink, VGH; Ganan, M; Gaustad, P; Lorentzen, SB; Sørlie, M | 1 |
| Afanaci, LF; Arias, LS; de Camargo, ER; de Lima, BH; de Lima, TM; de S Neto, FN; Ferraresse, RF; Monteiro, DR; Pessan, JP; Straioto, FG | 1 |
| Arias, LS; Brown, JL; Butcher, MC; Delaney, C; Kean, R; McKloud, E; Monteiro, DR; Ramage, G; Short, B; Williams, C | 1 |
| Chang, CJ; Deng, FS; Lin, CH; Lo, WH | 1 |
| Ahmed, N; Asad, MI; Khalid, A; Khan, GM; Qindeel, M; Ur Rehman, A | 1 |
| Furuishi, T; Kraisit, P; Limmatvapirat, S; Mahadlek, J; Yonemochi, E | 1 |
| de Lapena, SAB; Junqueira, JC; Melo, VMM; Rossoni, RD; Terra-Garcia, M; Ward, RADC | 1 |
| Akhir, A; Bhatta, RS; Bisen, AC; Chopra, S; Kedar, A; Krishna, A; Mugale, MN; Sanap, SN; Yadav, KS | 1 |
| Ghormade, V; Jadhav, S; Kolge, H; Patil, G | 1 |
| Abdel-Aziz, HMM; El-Zayat, MM; Hasaneen, MNA; Helal, SH | 1 |
| Howattanapanich, S; Matangkasombut, O; Satitviboon, W; Thanyasrisung, P | 1 |
| Araujo, HC; Caldeirão, ACM; Constantino, CJL; Delbem, ACB; Monteiro, DR; Oliveira, MJDS; Oliveira, SHP; Pessan, JP; Ramage, G; Sales, DH; Sampaio, C; Teixeira, SR | 1 |
| Alves, SF; Amaral, AC; Costa, AF; da Silva, JT; Dantas de Sousa, PH; de Menezes, LB; Pellegrini, F | 1 |
1 review(s) available for fluconazole and chitosan
| Article | Year |
|---|---|
Conventional and natural compounds for the treatment of dermatophytosis.
Topics: Antifungal Agents; Arthrodermataceae; Biological Products; Chitosan; Dermatomycoses; Fluconazole; Hair; Humans; Nails; Oils, Volatile; Skin; Terbinafine | 2020 |
23 other study(ies) available for fluconazole and chitosan
| Article | Year |
|---|---|
Tailoring the release rates of fluconazole using solid dispersions in polymer blends.
Topics: Antifungal Agents; Chitosan; Delayed-Action Preparations; Drug Carriers; Fluconazole; Hypromellose Derivatives; Methylcellulose; Particle Size; Polymers; Povidone; Solubility; Wettability | 2008 |
Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Chitosan; Culture Media; Drug Synergism; Fluconazole; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Molecular Weight | 2010 |
Antifungal and post-antifungal effects of chlorhexidine, fluconazole, chitosan and its combinations on Candida albicans.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Candida albicans; Chitosan; Chlorhexidine; Fluconazole; Humans | 2011 |
Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Topics: Administration, Topical; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Chitosan; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Excipients; Eye Infections, Fungal; Fluconazole; Gels; Microdialysis; Ophthalmic Solutions; Permeability; Poloxamer; Rabbits; Swine; Temperature | 2011 |
Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane Permeability; Chitosan; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Gene Expression Regulation, Fungal; Haploinsufficiency; Monomeric GTP-Binding Proteins; Naphthalenes; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Terbinafine; Vesicular Transport Proteins | 2012 |
Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Topics: Animals; Antifungal Agents; Apoptosis; Biofilms; Candida albicans; Candidiasis; Catheter-Related Infections; Catheterization, Central Venous; Chitosan; Disease Models, Animal; Drug Therapy, Combination; Female; Fluconazole; Fungal Polysaccharides; Hyphae; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles; Nitric Oxide; Nitric Oxide Donors; Organosilicon Compounds; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Voriconazole | 2016 |
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cattle; Chitosan; CHO Cells; Cricetulus; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Stability; Fluconazole; Male; Mouth Mucosa; Nanoparticles; Particle Size; Polymethacrylic Acids; Rabbits | 2016 |
Formulation and In Vitro Characterization of Thiolated Buccoadhesive Film of Fluconazole.
Topics: Adhesives; Administration, Buccal; Antifungal Agents; Carboxymethylcellulose Sodium; Chitosan; Cysteine; Drug Delivery Systems; Fluconazole; Sulfhydryl Compounds; Thioglycolates | 2017 |
Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chitosan; Fluconazole; Linoleic Acid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction; Zinc Oxide | 2017 |
Augmented control of drug-resistant Candida spp. via fluconazole loading into fungal chitosan nanoparticles.
Topics: Candida; Chitosan; Delayed-Action Preparations; Drug Resistance, Fungal; Fluconazole; Fungal Polysaccharides; Mucorales | 2019 |
Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chitosan; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Microbial Sensitivity Tests; Polymerization; Proton Magnetic Resonance Spectroscopy | 2019 |
Assembly and antifungal effect of a new fluconazole-carrier nanosystem.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Chitosan; Drug Carriers; Drug Compounding; Fluconazole; Microbial Sensitivity Tests; Nanoparticles | 2020 |
Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model.
Topics: Animals; Antifungal Agents; Candida; Chitosan; Fluconazole; Virulence | 2020 |
Synergistic Antifungal Activity of Chitosan with Fluconazole against
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Chitosan; Drug Resistance, Fungal; Fluconazole | 2020 |
Development of novel biopolymer-based nanoparticles loaded cream for potential treatment of topical fungal infections.
Topics: Chitosan; Drug Carriers; Drug Liberation; Fluconazole; Humans; Mycoses; Nanoparticles; Particle Size | 2021 |
Chitosan film containing antifungal agent-loaded SLNs for the treatment of candidiasis using a Box-Behnken design.
Topics: Adhesiveness; Administration, Buccal; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chitosan; Drug Carriers; Drug Delivery Systems; Fluconazole; Glycerides; Liposomes; Mouth Mucosa; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Swine | 2022 |
Enhancing effect of chitosan on methylene blue-mediated photodynamic therapy against C. albicans: A study in planktonic growth, biofilms, and persister cells.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Candida; Candida albicans; Chitosan; Fluconazole; Methylene Blue; Photochemotherapy; Photosensitizing Agents; Plankton | 2022 |
Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Fluconazole; Humans; Keratitis; Ofloxacin | 2022 |
A pH-tuned chitosan-PLGA nanocarrier for fluconazole delivery reduces toxicity and improves efficacy against resistant Candida.
Topics: Antifungal Agents; Candida; Candida albicans; Chitosan; Drug Resistance, Fungal; Fluconazole; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 2023 |
Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals.
Topics: Antifungal Agents; Chitosan; Fluconazole; Nanoparticles; Nanotubes, Carbon; Nystatin | 2022 |
Antifungal drug resistance in oral Candida isolates from HIV-infected and healthy individuals and efficacy of chitosan as an alternative antifungal agent.
Topics: Amphotericin B; Antifungal Agents; Candida; Chitosan; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests | 2023 |
Dual nanocarrier of chlorhexidine and fluconazole: Physicochemical characterization and effects on microcosm biofilms and oral keratinocytes.
Topics: Biofilms; Candida; Candida albicans; Chitosan; Chlorhexidine; Fluconazole; Humans; Keratinocytes; Streptococcus mutans | 2023 |
Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Disease Models, Animal; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Nanoparticles; Propolis; Rodent Diseases | 2023 |